Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure

Transfusion and Apheresis Science

Volumn 40, Issue 1, 2009, Pages 49-53

  Matsuda, Kenichi ^a   Moriguchi, Takeshi ^a   Harii, Norikazu ^a   Goto, Junko ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Blood purification; Continuous hemodiafiltration (CHDF); Hypercytokinemia; Polymethyl methacrylate membrane; Septic acute renal failure

Indexed keywords

CYTOKINE; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; FILTER; HUMAN; SEPSIS; SURVIVAL; URINE VOLUME;

ACRYLIC RESINS; ACRYLONITRILE; AGED; DISEASE-FREE SURVIVAL; FEMALE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; POLYMETHYL METHACRYLATE; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL RATE;

EID: 59649115329     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2008.11.003     Document Type: Article

References (26)

1. Ronco C., Bonello M., Bordonia V., Ricci Z., D'Intini V., Bellomo R., and Levin N.W. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 22 (2004) 164-174
2. Honore P.M., and Joannes-Boyau O. High-volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 27 (2004) 1077-1082
3. Di Carlo J.V., and Alexander S.R. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs 28 (2005) 777-786
4. Honore P.M., Joannes-Boyaub O., and Gressensa B. Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol 156 (2007) 387-395
5. Ronco C., Bellomo R., Homel P., Brendolan A., Dan M., Piccinni P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 355 (2000) 26-30
6. Matsuda K., Hirasawa H., Oda S., Shiga H., and Nakanishi K. Current topics on cytokine removal technologies. Ther Apher 5 (2001) 306-314
7. Busund R., Koukline V., Utrobin U., and Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 28 (2002) 1434-1439
8. Piccinni P., Dan M., Barbacini S., Carraro R., Lieta E., Marafon S., et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32 (2006) 80-86
9. Saudan P., Niederberger M., Seigneux S.D., Romand J., Pugin J., Perneger T., et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70 (2006) 1312-1317
10. Oda S., Hirasawa H., Shiga H., Nakanishi K., Matsuda K., and Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher 6 (2002) 193-198
11. Oda S., Hirasawa H., Shiga H., Matsuda K., Nakamura M., Watanabe E., et al. Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter. Ther Apher 9 (2005) 355-361
12. Nakada T., Hirasawa H., Oda S., Shiga H., and Matsuda K. Blood purification for hypercytokinemia. Transfus Apher Sci 35 (2006) 253-264
13. Hirasawa H., Oda S., and Matsuda K. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 156 (2007) 365-370
14. Nakada T., Oda S., Matsuda K., Sadahiro T., Nakamura M., Abe R., et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med 14 (2008) 257-263
15. Haase M., Silvester W., Uchino S., Goldsmith D., Davenport P., Tipping P., et al. A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 30 (2007) 108-117
16. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20: 864-74.
17. Vincent J.L., de Mendonca A., Cantraine F., Moreno R., Takala J., Suter P., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26 (1998) 1793-1800
18. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
19. Hirasawa H., Odaka M., Kobayashi H., Soeda K., Kobayashi S., Murotani N., et al. Hemopurification in the treatment of patients with multiple organ failure. In: Nose Y., Kjellstrand C., and Ivanovich P. (Eds). Progress in artificial organs-1985 (1986), ISAO Press, Cleveland 730-734
20. Stein B., Pfenninger E., Gruenert A., Schmitz J.E., and Hudde M. Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 16 (1990) 494-499
21. Hirasawa H., Sugai T., Ohtake Y., Oda S., Matsuda K., and Kitamura N. Blood purification for prevention and treatment of multiple organ failure. World J Surg 20 (1996) 482-486
22. Kellum J.A. Immunomodulation in sepsis: the role of hemofiltration. Minerva Anestesiol 65 (1999) 410-418
23. De Vriese A.S., Vanholder R.C., Pascual MLameire N.H., and Colardyn F.A. Can inflammatory cytokines be removed efficiency by continuous renal replacement therapies?. Intensive Care Med 25 (1999) 903-910
24. Rogiers P. Hemofiltration treatment for sepsis: is it time for controlled trials?. Kidney Int 72 Suppl (1999) S99-S103
25. Honore P.M., Joannes-Boyau O., Merson L., Boer W., Piette V., Galloy A.C., et al. The big bang of hemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification!. Int J Artif Organs 29 (2006) 649-659
26. Bellomo R. Do we know the optimal dose for renal replacement therapy in the intensive care unit?. Kidney Int 70 (2006) 1202-1204